Abstract

ObjectivesAs a result of the increasing number of diagnostic scans, incidental findings (IFs) are more frequently encountered during oncological work-up in patients with head and neck squamous cell carcinomas (HNSCC). IFs are unintentional discoveries found on diagnostic imaging. Relevant IFs implicate clinical consequences, resulting in delay in oncologic treatment initiation, which is associated with unfavorable outcomes. This study is the first to investigate the incidence and nature of IFs over the years and establish the effect of relevant IFs on delay. Material and methodsThis retrospective study compared two time periods (2010–2011 and 2016–2017), described associations between relevant IFs and delay in carepathway interval (days between first visit and treatment initiation) and assessed the effect of relevant IFs on overall two-year survival. ResultsIn total, 592 patients were included. At least one IF was found in 61.5% of the patients, most frequently on chest-CT. In 128 patients (21.6%) a relevant IF was identified, resulting for the majority in radiologist recommendations (e.g. additional scanning). Presence of a relevant IF was an independent significant factor associated with delay in treatment initiation. The risk of dying was higher for patients with a relevant IF, although not significant in the multivariable model (HR: 1.46, p = 0.079). ConclusionIn diagnostic work-up for HNSCC patients, relevant IFs are frequently encountered. As the frequency of additional imaging rises over the years, the number of IFs increased simultaneously. These relevant IFs yield clinical implications and this study described that relevant IFs result in significant delay in treatment initiation.

Highlights

  • head and neck squamous cell carcinomas (HNSCC) are relatively fast-growing tumors and most patients present with advanced disease stages [1,2]

  • The presence of relevant incidental findings (IFs) was indepen­ dently associated with delay in treatment initiation (OR: 1.879, 95%CI: 1.08–3.28, p = 0.026)

  • Our results demonstrated 10.1% of the relevant IFs to be malignant disease, similar to other reports [11,12]

Read more

Summary

Introduction

HNSCC are relatively fast-growing tumors and most patients present with advanced disease stages [1,2]. During diagnostic work-up, the goal is adequate staging by evaluating the extent of disease and identify second primaries in order to set up an individualized treatment plan according to international guidelines. As a result of fast tumor growth, delay in treatment initiation is associated with tumor progression, more extensive treatment and decreased overall survival [3,4,5]. In the Netherlands, the guideline states that 80% of the patients has to start treatment within 30 days after first consultation (carepathway in­ terval: CPI) in an oncological center [6]. The cut-off for CPI in Denmark is even more challenging: 22 days for initial surgery and 26 days for radiotherapy [7]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call